Concepedia

Gi‐Ming Lai

GL

Statistics

Publications

50

Citations

3K

H-Index

31

Active since

1988

Affiliations

National Health Research Institutes(Current)

Taipei Medical University

Wan Fang Hospital

National Taiwan University Hospital

National Defense Medical Center

Gi‐Ming Lai is an author at National Health Research Institutes specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1988–2022

50

Publications

50

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.

Hidetaka Masuda, R F Ozols, Gi‐Ming Lai et al. · PubMed · 1988 · 284 citations

, , +17

Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia

Chih-Chen Hong, Jong-Ding Lay, Jhy-Shrian Huang et al. · Cancer Letters · 2008 · 225 citations

, , +17

P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

Gi‐Ming Lai, Y N Chen, Lyn A. Mickley et al. · International Journal of Cancer · 1991 · 176 citations

, , +15

Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan.

Hao Wu, Yi‐Ping Chuang, Anne Lynn S. Chang et al. · PubMed · 1990 · 163 citations

, , +17

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

Shuang‐En Chuang, Pei-Yen Yeh, Yen‐Shen Lu et al. · Biochemical Pharmacology · 2002 · 157 citations

, , +16

1–5 of 50